Variable | Failure (n = 6) | Success (n = 20) | p value |
---|---|---|---|
Age* | 69.8 (8.7) | 74.5 (6.7) | 0.18 |
Gender | 0.66 | ||
Male | 3 (20) | 12 (80) | |
Female | 3 (27.2) | 8 (72.7) | |
Side | 0.47 | ||
Right | 4 (28.5) | 10 (71.4) | |
Left | 2 (16.6) | 10 (83.3) | |
Smoker | 1 (50) | 1 (50) | 0.34 |
Body mass index* | 30.4 (3.4) | 30 (2.6) | 0.62 |
Deyo-Charlson Index* | 5.1 (2.9) | 4.0 (1.4) | 0.47 |
ASA | 0.12 | ||
I | 0 (0) | 1 (100) | |
II | 4 (33.3) | 8 (66.6) | |
III | 1 (8.3) | 11 (91.6) | |
IV | 1 (100) | 0 (0) | |
Comorbidities | |||
DM | 1 (25) | 3 (75) | 0.92 |
Obesity (BMI > 30 kg/m2) | 3 (25) | 9 (75) | 0.82 |
Malignancy | 1 (50) | 1 (50) | 0.34 |
Hypertension | 6 (31.5) | 13 (68.4) | 0.09 |
Cardiac disease | 2 (66.6) | 1 (33.3) | 0.05 |
Chronic pulmonary disease | 4 (44.4) | 5 (55.5) | 0.05 |
Chronic renal failure | 1 (25) | 3 (75) | 0.92 |
Vascular disease | 1 (25) | 3 (75) | 0.92 |
Thyroid disease | 0 (0) | 1 (100) | 0.57 |
Rheumatoid arthritis | 0 (0) | 2 (100) | 0.42 |
Immunosuppressive therapy | 1 (25) | 3 (75) | 0.92 |
Steroid therapy | 3 (30) | 7 (70) | 0.50 |
Repetitive urine infection | 0 (0) | 3 (100) | 0.31 |